New Vaccine Trials Bring Hope in Fight Against Tuberculosis
Tuberculosis, known as TB, has reemerged as the world’s biggest infectious killer, raising concerns about the ongoing battle against this ancient disease. Health experts are now turning their hopes towards long-awaited trials for a potential new vaccine that could revolutionize the fight against TB.
Can a New Vaccine Change the Course of Tuberculosis?
Learn about the ongoing battle against tuberculosis (TB) in 2024 and the potential impact of new vaccines on this deadly disease. Despite existing preventive measures and treatments, TB continues to afflict millions globally, with over 10 million cases and 1.3 million deaths in 2022. Explore how novel TB vaccines targeting adolescents and adults offer hope for improved efficacy, marking a significant shift in the fight against this historic health threat.
Promising Findings in Bovine Tuberculosis Study
A recent study led by the University of Cambridge and Penn State University has revealed promising findings that could potentially lead to the elimination and control of bovine tuberculosis. The research indicates that vaccination not only reduces the severity of tuberculosis in infected cattle but also diminishes its spread in dairy herds by an impressive 89%. This groundbreaking discovery marks the first time that BCG-vaccinated cattle infected with tuberculosis have been shown to be significantly less infectious to other cattle, highlighting the indirect yet substantial impact of the vaccine beyond its direct protective effect.
Phase 3 Clinical Trial for TB Vaccine Underway in South Africa
Phase 3 clinical trial for M72/AS01E tuberculosis vaccine begins in South Africa, offering hope for prevention of pulmonary TB in adolescents and adults. The vaccine, supported by the Gates Foundation and Wellcome, could make a significant impact in low- and middle-income countries where TB takes a heavy toll.